Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,4 diazines > Piperazines (i.e., fully hydrogenated 1,4-diazines) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/252.12
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,4 diazines > Piperazines (i.e., fully hydrogenated 1,4-diazines)
Description: Subject matter wherein the 1,4-diazine ring is fully saturated.

Sub-classes under this class:

Class Number	Class Name	Patents
514/252.13	Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding	522
514/255.03	Carbocyclic ring bonded directly to the piperazine ring	402
514/255.02	Chalcogen bonded directly to a piperazine ring carbon	130
514/255.01	Nitrogen or -c(=x)-, wherein x is chalcogen, bonded directly to the piperazine ring	460
514/255.04	Plural carbocyclic rings bonded directly to the same acyclic carbon atom which is attached directly or indirectly to the piperazine ring by nonionic bonding	193

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11

Patent Number	Title Of Patent	Date Issued
7605161	Pyridyl derivatives and their use as therapeutic agents	Oct. 20, 2009
7601715	Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein	Oct. 13, 2009
7601720	Nicotinic receptor agonists for the treatment of inflammatory diseases	Oct. 13, 2009
7598242	Compounds for the treatment of inflammatory disorders	Oct. 6, 2009
7598249	Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase	Oct. 6, 2009
7595320	Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof	Sep. 29, 2009
7595343	Inhibitors of histone deacetylase	Sep. 29, 2009
7592344	NK1 and NK2-antagonists and compositions and methods of using the same	Sep. 22, 2009
7589094	N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds	Sep. 15, 2009
7585864	Farnesyl protein transferase inhibitors and their use to treat cancer	Sep. 8, 2009
7576110	Benzothiazole cyclobutyl amine derivatives	Aug. 18, 2009
7572790	Biphenyl carboxylic amide p38 kinase inhibitors	Aug. 11, 2009
7563781	Triazolopyrimidine derivatives	Jul. 21, 2009
7563789	1-Adamantyl chalcones for the treatment of proliferative disorders	Jul. 21, 2009
7553837	Phenylazole compounds production process and antioxidants	Jun. 30, 2009
7553831	Compounds to treat Alzheimer's disease	Jun. 30, 2009
7550467	Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders	Jun. 23, 2009
7550463	Carbamoylpyridone derivatives having inhibitory activity against HIV integrase	Jun. 23, 2009
7524846	Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use	Apr. 28, 2009
7521451	Isoindoline derivative	Apr. 21, 2009
7514431	Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity	Apr. 7, 2009
7494997	Amide derivative	Feb. 24, 2009
7491723	Alkanol and cycloalkanol-amine derivatives and methods of their use	Feb. 17, 2009
7485651	Compounds with activity on muscarinic receptors	Feb. 3, 2009
7482346	Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors	Jan. 27, 2009
7473690	Tetralin and indane derivatives and uses thereof	Jan. 6, 2009
7468371	Tricyclic pyrazole kinase inhibitors	Dec. 23, 2008
7449315	Bifunctional energy-reversible acyl-compositions	Nov. 11, 2008
7423048	Compounds for treating fundic disaccomodation	Sep. 9, 2008
7417042	Compounds for enzyme inhibition	Aug. 26, 2008
7417045	Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity	Aug. 26, 2008
7407985	Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments	Aug. 5, 2008
7399764	Inhibitors of Akt activity	Jul. 15, 2008
7393849	Substituted sulfonamides and ureas useful for inhibiting kinase activity	Jul. 1, 2008
7390812	N, N'-disubstituted piperazine compounds and their use as analgesics	Jun. 24, 2008
7384944	Piperazine derivatives useful as CCR5 antagonists	Jun. 10, 2008
7378412	Pharmaceutical compounds	May. 27, 2008
7378446	Compound having anti-HCV activity and process for producing the same	May. 27, 2008
7371755	Antiviral agents	May. 13, 2008
7368448	2-(arylalkoxy)-1-phenylethylamine derivatives as NK.sub.1 antagonist and serotonin reuptake inhibitors	May. 6, 2008
7365076	Substituted aryl cycloalkanol derivatives and methods of their use	Apr. 29, 2008
7365070	Modulators of melanocortin receptor	Apr. 29, 2008
7348328	MCH antagonists for the treatment of obesity	Mar. 25, 2008
7332494	Method for treating allergies using substituted pyrazoles	Feb. 19, 2008
7320978	Oxazole derivatives, preparation and therapeutic use thereof	Jan. 22, 2008
7317010	Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone	Jan. 8, 2008
7304065	Melanin concentrating hormone antagonists	Dec. 4, 2007
7300936	.alpha.-(N-sulfonamido)acetamide derivatives as .beta.-amyloid inhibitors	Nov. 27, 2007
7297697	4-(diarylmethyl)-1-piperazinyl derivatives	Nov. 20, 2007
7291633	6H-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands	Nov. 6, 2007